maps glp-1 Mapped: GLP-1s across the U.S.
Description
Contains Amarasate, a New Zealand hops flower extract

Fully-managed by us, under your brand.
And here we see in IQVIAs two charts the declining share of traditional diabetes therapies with growing new prescriptions for GLP-1 agonists a 5% share in 2019 and a 16% share in 2023

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.
